Is There a Link Between a Genetic Variation and Poor Myeloma Survival Rate?

In his blog this week, IMF Chairman Dr. Brian Durie comments on news about a multi-institutional study that found patients with multiple myeloma with a genetic variation in the gene FOPNL have poorer outcomes than patients without it. “As one might suspect, much further work is needed to substantiate and understand this finding,” he notes, “but this initial report is quite tantalizing.” To read Dr. Durie's blog, click HERE
Source: International Myeloma Foundation - Category: Hematology Source Type: news